REG - Mirae Asset ETF ICAV - Global X ETF ICAV 18.08.26London Stock Exchange·2 days ago, 03:27 AMBUG+0.85%PBE+1.22%
Chinese biotech overtakes AI as emerging-market growth tradeBusinesstimes News·Jul 26 at 10:14 PM300765-5.37%AZN+1.11%
10:30 ETSingle-use Bioreactors Market worth $9.58 billion by 2031 - Exclusive Report by MarketsandMarkets™prnewswire·Jul 23 at 09:31 AMLABD-5.79%IBBQ+1.77%
China's 1H25 Innovative Drug Out-Licensing Deal Value Exceeds USD100 Billion, Hitting New HighAASTOCKS News·Jul 20 at 01:00 AM510660-3.40%159992-4.49%
China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global TotalAASTOCKS News·Jul 20 at 01:00 AM513060-0.84%159859-4.60%
With a net inflow of 130 billion yuan in the past week, who is buying up broad-based and STAR Market ETFs?CoinLive·Jul 16 at 09:19 AM000300+0.57%000688+0.04%
China's Outbound Licensing of Innovative Drugs in First Half Nears Last Year's TotalYicai·Jul 13 at 02:28 AM159859-4.60%513700-0.76%
Global Pharmacogenomic Testing Service Market to Register Stunning Growth at a CAGR of ~12% by 2034 | DelveInsightUnusual Whales·Jul 9 at 09:47 AMARKG+3.34%516930-3.90%
China’s biotech boom: RAS-targeted drugs challenge US dominanceSCMP·Jul 8 at 03:05 AM01276-2.94%600276-3.56%
AI hype is 'blarney', semi stock prices will normalize: Bank Julius BaerMSN·Jun 25 at 09:15 PM513120-0.97%159837-4.59%
China’s biotech boom: record 5,215 clinical drug trials reported in 2025SCMP·Jun 23 at 07:02 PM159615-0.76%159992-4.49%
09:00 ETU.S. Biomedical Innovation Leadership at Risk: New Data Show China Rapidly Closing Gap as Clinical Trials and Manufacturing Migrate Abroadprnewswire·Jun 22 at 08:00 AM512290-3.77%159859-4.60%
Biopharma bounces back as M&A impetus fuels recoveryPharmaceutical Technology·Jun 17 at 11:17 AM159859-4.60%159506-1.56%
10:01 ETPD-L1 Biomarker Testing Market to Reach USD 1,830.7 Million by 2036 as Precision Oncology and Immunotherapy Adoption Accelerate Global Demandprnewswire·Jun 16 at 09:02 AMLABD-5.79%159892-0.85%
